J Rosenstock, MA Baron, S Dejager, D Mills, … - Diabetes Care, 2007 - Am Diabetes Assoc RESULTS—Monotherapy with vildagliptin and rosiglitazone decreased A1C
(baseline = 8.7%) to a similar extent during the 24-week treatment, with most of
the A1C reduction achieved by weeks 12 and 16, respectively. At end point, ... Cited by 21 - Related articles - All 5 versions
- Free from Publisher J Rosenstock, MA Baron, S Dejager, D Mills, … - Diabetes Care, 2007 - ncbi.nlm.nih.gov OBJECTIVE: To compare the efficacy and tolerability of vildagliptin and
rosiglitazone during a 24-week treatment in drug-naïve patients with type 2
diabetes. RESEARCH DESIGN AND METHODS: This was a double-blind, randomized, ... Cited by 142 - Related articles - BL Direct - All 5 versions
IW Campbell, C Day - The British Journal of Diabetes & Vascular Disease, 2007 - secure.sherbornegibbs.com Introduction During the early 20th century much experimentation was undertaken
to elicit the chemical entities which stimulated the pancreas, and in 1932 J. La
Barre proposed the term incretin for a hypoglycaemia-inducing hormone(s) ... Cited by 4 - Related articles - View as HTML - All 8 versions
A Schweizer, A Couturier, JE Foley, S Dejager - Diabetic Medicine, 2007 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 89 - Related articles - BL Direct - All 4 versions
C Pan, W Yang, JP Barona, Y Wang, M Niggli … - Diabetic Medicine, 2008 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 16 - Related articles - BL Direct - All 4 versions
AJ Garber, A Schweizer, MA Baron, E … - Diabetes, Obesity and Metabolism, 2007 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 109 - Related articles - All 5 versions
- ►diabetesjournals.org E Bosi, RP Camisasca, C Collober, E … - Diabetes Care, 2007 - Am Diabetes Assoc RESULTS—The between-treatment difference (vildagliptin − placebo) in
adjusted mean change (AMΔ) ± SE in A1C from baseline to end point was −0.7
± 0.1% (P < 0.001) and −1.1 ± 0.1% (P < 0.001) in patients receiving 50 ... Cited by 147 - Related articles - BL Direct - All 10 versions
G Bolli, F Dotta, E Rochotte, SE Cohen - Diabetes Obes Metab, 2008 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 49 - Related articles - All 2 versions
[CITATION] Januvia, Summary of Product Characteristics. emc. medicines. org. uk
